filmov
tv
Checkpoint Inhibitors: Taking the Brakes Off the Immune System
Показать описание
Checkpoint inhibitors are a very promising avenue for treating cancer. Imagine the immune system is a car, complete with brake and accelerator pedals, telling it when to move forward and attack, and when to stay still. Checkpoint inhibitors disengage the immune system’s brakes, allowing it to attack the cancer cells at full speed. Already approved to treat melanoma and certain lung cancers, therapies like Yervoy (ipilimumab), Keytruda (pembrolizumab), Opdivo (nivolumab), and others may have applications in dozens of additional cancer types.
Checkpoint Inhibitors: Taking the Brakes Off the Immune System
Checkpoint inhibitors in cancer therapy | Peter Attia, M.D. & Steven Rosenberg, M.D., Ph.D.
Dr. Michael Lim on Toxicities of Checkpoint Inhibitors
Taking the Brakes Off the Immune System, with Dr. James P. Allison
What are Immune Checkpoints?
Immunotherapy: Checkpoint Inhibitors
What are checkpoint inhibitors? #myeloma
Immune checkpoint inhibitors: recent progress and potential biomarkers - 1iv Introduction
Side effect profile of checkpoint inhibitors
Immune checkpoint inhibitors: recent progress and potential biomarkers - 1v Introduction
Treatment of Bladder Cancer-Immune Checkpoint Inhibitors
Immune Checkpoint Inhibitors & Co-Stimulatory Molecules | Presented by Dr. Philippe Bedard
2017 Spring Symposium: Update on Cancer Immunotherapy
Dr. Michael Lim on Toxicities of Checkpoint Inhibitors in Glioblastoma
Immune adverse events of checkpoint inhibitors
Immune Checkpoint Inhibitors In Renal Cell Carcinoma
The Hunt for New Checkpoint Inhibitors - Amgen Science
Understanding Immunotherapy for Lung Cancer
PD-L1/PD-1 Pathway: A Security Checkpoint
Immune checkpoint inhibitors: recent progress and potential biomarkers - 7i Concluding remarks
Research needs to address neurologic complications of immune checkpoint inhibitor use
Chemoimmunotherapy After Failure on Checkpoint Inhibitor Treatment for Metastatic Melanoma
Targeting Checkpoint Inhibitors for Cancer Treatment: The Possibilities
How Immunotherapy Is Improving Treatment for Melanoma | GoodRx
Комментарии